Considerable progress has been made in converting human pluripotent stem cells (hPSCs) into functional neurons. However, the protracted timing of human neuron specification and functional maturation remains a key challenge that hampers the routine application of hPSC-derived lineages in disease modeling and regenerative medicine. Using a combinatorial smallmolecule screen, we previously identified conditions to rapidly differentiate hPSCs into peripheral sensory neurons. Here we generalize the approach to central nervous system (CNS) fates by developing a small-molecule approach for accelerated induction of early-born cortical neurons. Combinatorial application of six pathway inhibitors induces post-mitotic cortical neurons with functional electrophysiological properties by day 16 of differentiation, in the absence of glial cell co-culture. The resulting neurons, transplanted at 8 d of differentiation into the postnatal mouse cortex, are functional and establish long-distance projections, as shown using iDISCO whole-brain imaging. Accelerated differentiation into cortical neuron fates should facilitate hPSC-based strategies for disease modeling and cell therapy in CNS disorders. hESC lines and hiPSC line generation. hESCs (WA09; passages 32-60) were obtained from WiCell and maintained up to passage 60. The hESC SOX10:: GFP bacterial artificial chromosome reporter line (WA09; passage 40-70) was generated as reported previously 7 . Constitutive EGFP + hESC line (WA09; passage 35-60) was generated as reported 29 . RUES2 cell line used for deriving CUX2 conditional reporter line was generated at the Rockefeller University as described at http://rues.rockefeller.edu. For hiPSC induction, fibroblasts were prepared by digesting skin-punch biopsies following a protocol shared by M. Sheldon. Briefly, skin punches were digested in a mixture of collagenase (1%) and dispase (1 U/ml; Stem Cell Technology) in DMEM+10% FBS for 16-18 h at 37 °C in a tissue culture incubator. After digestion, the epidermal layer was discarded and the partially digested dermal layer was quartered onto the surface of a dry tissue culture dish and was left undisturbed for 2-5 min to encourage adhesion to the dish. DMEM+10% FBS was carefully added to the well so as not to detach the dermal layer. Cultures were fed every 3 d until confluent foci covered ~2/3 of the well. Once confluent, cultures were passaged by trypsinization and expanded for 4-5 passages before reprogramming. iPSCs were made using the original CytoTune iPS Reprogramming Kit (A1378002; Life Technologies) using the manufacturer's protocol with a few modifications. Human ES medium containing 1 mM valproic acid (EMD Millipore) was added from days 2-9. After 2-3 weeks, individual iPS clones were picked and propagated as iPS lines. To verify that each of the three iPS subclones from a given individual were truly nonclonal, we picked colonies from 3 different wells that derived from 3 separate transductions. Each line was propagated for 10 passages before performing quality control assays. We first confirmed expression of OCT4, NANOG, SSEA-3, SSEA-4 and Tra-1-81. Clones that expressed all pluripotency markers were verified to have a normal karyotype by the Molecular Cytogenetics Core Facility at Memorial Sloan Kettering Cancer Center (MSKCC). The amount of Sendai vector present after 10 passages was quantified using the TaqMan iPSC Sendai Detection Kit (A13640; Life Technologies), and only clones with less than 0.01% Sendai virus amplicon (Mr04269880_mr) were used. All the hPSCs lines used for this study were tested for mycoplasma contamination every 2 weeks, and hPSC line identity was authenticated by STR analysis.
A r t i c l e s Over the past few years, methods have been developed to convert hPSCs into early neural lineages. A particularly efficient strategy is the use of two small-molecule inhibitors of SMAD signaling (LDN193189 and SB431542; referred to as the LSB protocol) to trigger differentiation of human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) into PAX6 + CNS neural precursors within 11 d of differentiation 1 . Neural subtype specification can be further modulated using additional small molecules targeting pathways such as WNT signaling. Timed exposure to compounds activating WNT signaling under dual SMAD inhibition conditions induces the neural crest lineage, marked by SOX10 expression. In contrast, inhibition of WNT signaling blocks the formation of neural crest cells and enhances the induction of forebrain precursors, marked by FOXG1 expression [2] [3] [4] . Although those manipulations efficiently specify defined neural precursor cell populations, further differentiation into functional neurons in vitro is a lengthy process that can extend over weeks if not months.
To accelerate neuronal fate acquisition, we have used two additional small molecules: SU5402, a potent inhibitor of fibroblast growth factor (FGF) signaling 5 , and DAPT, a γ-secretase inhibitor blocking Notch signaling 6 . Combinatorial application of those two inhibitors with dual SMAD inhibition and WNT activation yields 75% post-mitotic neurons in 11 d of differentiation 7 , the same time period required for neural precursor cell induction under standard dual SMAD inhibition conditions 1 . However, coexpression of BRN3A and ISL1 in those rapidly induced neurons defined them as peripheral sensory rather than PAX6-derived CNS neurons 7 . Therefore, it has remained unclear whether strategies to accelerate neuronal fate acquisition during sensory fate specification can be adapted for CNS fates. PAX6-derived cortical neurons are of particular interest for studies of human development and for modeling human neurodevelopmental and neurodegenerative disorders. While reliable protocols exist to derive cortical neurons from hPSCs, those conditions require 30-90 d of differentiation to yield both lower-and upper-layer cortical neurons 8, 9 and even longer time periods to achieve full maturation.
Here we sought to identify small-molecule-based conditions that accelerate human cortical neuron fate induction to facilitate the routine application of hPSC-derived neurons in disease modeling and regenerative medicine. We present modified small-molecule-based differentiation conditions that sharply accelerate the derivation of forebrain neurons in the presence of WNT pathway inhibitors. Phenotypic marker expression, electrophysiological analysis, and in vivo transplantation studies confirm neuronal identity and functional properties of the cells, indicating that strategies for accelerated combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells
RESULTS

Development of an accelerated CNS neuron differentiation protocol
Given the critical roles of WNT signaling in determining fate choice between the CNS and neural crest 3, 10 , we hypothesized that developing a combinatorial small-molecule approach that inhibits rather than activates WNT signaling may trigger rapid differentiation toward cortical neurons (Fig. 1a) . To test this hypothesis, we replaced the GSK3β inhibitor CHIR99021 (C; WNT agonist) with the tankyrase inhibitor XAV939 (X; WNT antagonist), which acts to stabilize Axin 11 . All other inhibitors used previously for the derivation of sensory neurons (LSB, SU5402 (S; FGF antagonist), and DAPT (D; Notch antagonist)) remained unchanged for these initial studies aimed at rapidly inducing forebrain neuron fates (LSB+X/S/D protocol).
In light of our past experience in unexpectedly triggering a CNS to peripheral nervous system (PNS) fate switch during rapid neuronal induction 7 , we first assessed the impact of the LSB+X/S/D condition on early ectodermal lineage choice using three engineered hESC reporter lines: PAX6::H2B-GFP (CNS lineage), SOX10::GFP 2,7 (neural crest fate), and SIX1::H2B-GFP line 12 (cranial placode fate). Faithfulness of reporter expression was validated after directed in vitro differentiation into the respective fates 1,2,13 ( Fig. 1b) . Consistent with previous work, both LSB and LSB+X conditions gave rise to a nearuniform population (>95%) of PAX6 + cells, with few cells expressing SOX10 or SIX1 (Fig. 1c) . In contrast, LSB+C or LSB+C/S/D (also referred to as 3i (ref. 7) or PNS sensory neuron protocol) gave rise to only a few cells expressing PAX6, but a large percentage of SOX10 + neural crest precursors, consistent with the important role of WNT signaling in neural crest induction 7 . LSB+X/S/D, our candidate protocol for rapid induction of CNS neurons, gave rise to an almost pure population (>98%) of PAX6 + cells as early as day 6 of differentiation. This accelerated timing was consistent with the role for FGF inhibition in exiting pluripotency in hPSCs 14 (Fig. 1c) .
Next, we assessed whether the LSB+X/S/D condition can induce putative CNS neurons with efficiencies similar to those reported for the rapid induction of sensory neurons 7 . Intracellular flow cytometry for β-III tubulin (TUJ1), a pan-neuronal marker, showed that the LSB+X/S/D condition gave rise to only 10% TUJ1 + neurons at day 13 of differentiation compared to >40% in the 3i condition 7 (Fig. 1d-f ). These data indicate that inhibition of WNT signaling in the presence of SU5402 and DAPT rapidly induced CNS lineage but triggered neuronal differentiation at only moderate efficiency compared to PNS sensory neuron conditions.
In an effort to enhance the neuronal conversion efficiency, we performed a targeted small-molecule screen using the CNS differentiation condition without acceleration (LSB+X). We selected molecules targeting signaling pathways involved in neural precursor cell proliferation, such as SHH (cyclopamine, Cur-61414, purmorphamine), PI3K and PDGFR (LY-294002, imatinib), MYC/bromodomain proteins (JQ1), retinoid signaling (all-trans retinoic acid), TGF-β activation (IDE-1), HMG-CoA reductase inhibition (lovastatin) and the nicotinamide phosphoribosyltransferase inhibition (P7C3), as well as signaling pathways downstream of FGF receptor activation, including ERK signaling (PD0325901). Only PD0325901, an orally bioavailable, potent inhibitor for mitogen-activated protein kinase (MAPK/ERK kinase or MEK) 10 , enhanced neuronal differentiation under LSB+X. Inhibition of ERK1/2 in the mouse causes premature neuronal differentiation during cortical development 15 , and ERK inhibition has been previously proposed as a strategy to enhance overall neuronal differentiation in hPSCs 16 . PD0325901 could boost the yield of TUJ1 + neurons to >50%, a value approximating the efficiency of the 3i protocol for generating sensory neurons, but only when used at high concentrations ( Fig. 1g, top) , resulting in a low yield in total cell numbers (Fig. 1g, bottom) . Improved yields in total neuron numbers were obtained when lower PD0325901 concentrations were combined with SU5402 exposure in an effort to balance neuronal induction efficiency with overall cell loss. Additional treatment with DAPT did not affect overall neuron yield but further increased the efficiency of neuronal induction. To understand whether reduced yield is due to rapid cell cycle exit or direct toxicity, we measured phospho-histone 3 and cleaved caspase 3 as markers of cell proliferation and death, respectively. Exposure to both PD0325901 (P) and SU5402 reduced cell proliferation as early as 24 h after P/S treatment, whereas cell death was observed only at high doses of SU5402 ( Supplementary  Fig. 1a-f ), implicating restriction of precursor cell proliferation as a key factor in the rapid neuronal differentiation response. We selected two conditions for all subsequent studies that produced high percentages and high total yields of neurons: (i) PD0325901 (1 µM) + SU5402 (5 µM) + D (10 µM) is referred to as the 'P1S5D condition'; and (ii) PD0325901 (8 µM) + SU5402 (10 µM) + D (10 µM) as the 'P8S10D condition' (Fig. 1h,i) .
Phenotypic analysis of CNS and cortical neuron identity
We next determined the efficiency of P1S5D and P8S10D as cocktails for the rapid induction of CNS neurons ( Fig. 2a) . The P8S10D condition resulted in the most dramatic acceleration of neuronal fate acquisition ( Fig. 2b and Supplementary Fig. 2a ), generating 70% of TUJ1 + neurons by 13 d of differentiation. Gene expression analysis confirmed downregulation of the pluripotency marker OCT4 and induction of neural and neuronal markers PAX6, FOXG1 and DCX, as well as markers of early-born cortical neurons, including TBR1 (preplate, subplate and layer VI) and REELIN, in LSB+X/P/S/D conditions. In contrast, the sensory neuron (3i) and the CNS induction protocol without acceleration (LSB+X) showed lack of cortical or neuronal marker induction, respectively ( Fig. 2c) . Given the weak induction of the forebrain marker FOXG1 under the P8S10D condition, we tested the impact of each small molecule on FOXG1 expression ( Supplementary Fig. 2b,c) . In particular, the exposure to PD0325901 dramatically reduced the efficiency of FOXG1 induction. However, TBR1 was expressed in >50% of TUJ1 + cells at day 13 in both P1S5D and P8S10D conditions ( Fig. 2d-f) , with similar expression of the layer VI marker TLE4 (Supplementary Fig. 3a) .
To identify the remaining neurons that were negative for TBR1 and TLE4, we screened a panel of additional markers at day 13 ( Supplementary Table 1 and Supplementary Fig. 3b) . Surprisingly, 15-20% neurons expressed BRN3A but only very few neurons expressed ISL1, suggesting the presence of a contaminating BRN3A + CNS lineage ( Supplementary Table 1 and Supplementary Fig. 3c,d) . On the basis of the expression of both BRN3A and GSX2 ( Supplementary Fig. 3b ), those noncortical neurons may correspond to an early thalamic lineage (http://www.gensat.org/; http://developingmouse.brain-map. org/). Characterization of the TUJ1 − fraction showed the presence of cells positive for TBR2, BLBP and CUX2 (Supplementary Table 1 and Supplementary Fig. 3a,b) , consistent with cortical precursor cell identity. We further observed upregulation (compared to LSB+X) of other anterior CNS and cortical progenitor and neuron markers in LSB+X/P/S/D conditions ( Supplementary Fig. 3b ). However, we did not detect the expression of ventral forebrain, cortical interneuron or other GABAergic neuron fates ( Supplementary Table 1 and Supplementary Fig. 3b) . 
A r t i c l e s
To determine whether LSB+X/P/S/D conditions were robust across multiple lines, we tested six independent hiPSC lines derived from two healthy individuals. By 13 d of differentiation, all lines were enriched for TBR1 + /TUJ1 + neurons and displayed morphologies similar to those obtained from the WA09 hESC line (Supplementary Fig. 4a,b) . Quantification of the percentages of neurons showed similar efficiency to that observed for WA09, although there was some variability across lines (Supplementary Fig. 4c ). In an effort to translate the accelerated protocol to GMP-compatible culture conditions, the protocol was further adapted to an Essential 6 medium (E6)-based induction platform (Fig. 2g) . We observed efficient PAX6 induction and accelerated generation of highly enriched populations of TBR1 + post-mitotic neurons by 13 d of differentiation ( Fig. 2h) . Thus, our rapid induction strategy can be applied across hiPSC lines and adapted to GMP-compatible culture conditions. During corticogenesis, projection neurons are produced in an inside-out manner 17 . The enrichment of TBR1 + neurons suggested a potential bias toward generating the earliest-born deep-layer cortical neurons. However, further maintenance of P1S5D or P8S10D cultures in the absence of FGF-ERK and Notch inhibition (days 13-55) ( Fig. 3a ) Immunocytochemistry 60
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Birth date analysis Figure 3 Generation of neurons constituting multiple cortical layers upon long-term culture. (a) Illustration of long-term culture protocols. In vitro differentiation before day 8 is the same as described in Figure 2a . For long-term culture, P1S5D and P8S10D cells were passaged at day 8 of differentiation at 150,000/cm 2 and 300,000/cm 2 , respectively, in NB/B27+BCA medium without additional inhibitors thereafter. Cells were fixed at various time points and processed for immunocytochemistry or RNA extraction and qRT-PCR analysis. A r t i c l e s enabled generation of neurons expressing markers representing a broader range of cortical layers, such as FOXP2 (layer V-VI), CTIP2 (layer V), SATB2 (layer II-III, V), and RGS4 (layers II-III, V) ( Fig. 3b  and Supplementary Fig. 5) , as well as generation of upper layer CUX2 + (layers II-IV) neurons monitored by using a tamoxifen-inducible CUX2 reporter hESC line (Supplementary Fig. 6a-d) . P1S5D-or P8S10D-treated cells started to produce CUX2 + post-mitotic neurons with mature morphologies as early as day 33, compared to day 55 using a protocol without acceleration (Supplementary Fig. 6e-g) . While cortical neurogenesis was considerably accelerated, no A r t i c l e s upregulation of glial markers, such as GFAP, AQP4 or OLIG2 was observed. Similarly, there was no induction of retinal fate markers such as CHX10 (Supplementary Fig. 5 ). The quantification of TBR1 + , CTIP2 + and SATB2 + neurons (Fig. 3c) suggested that in vitro-derived neurons may follow a temporal order of marker expression consistent with in vivo corticogenesis. To further address the specific timing of neuron subtype derivation in vitro, we performed birth-dating experiments (Fig. 3a) . 5-Ethynyl-2-deoxyuridine (EdU) colabeling with layer-specific markers showed successive waves of cell birth (Fig. 3d,e) . Thus, our data demonstrate highly efficient induction of layer VI and indicate the feasibility of accelerated derivation of upperlayer neurons using a modified small-molecule timing regimen.
Rapid induction of neuronal function
We next addressed whether rapid induction of neuronal markers is paralleled by rapid in vitro maturation, such as the ability to spontaneously fire repetitive action potentials. Functional maturation of hPSC-derived neurons has been previously demonstrated 8, 9 , with firing of action potentials typically occurring at about 50-100 d of differentiation. To investigate maturation, we cultured cells under P1S5D or P8S10D conditions for 8 d followed by an additional 8 d in (i) basal medium without any small molecules, (ii) addition of DAPT only or (iii) addition of DAPT with SU5402, PD0325901 and CHIR99021 (P/S/D/C) (Fig. 4a) . The WNT agonist CHIR99021 was included for this final differentiation step, as it exerted a strong pro-survival effect on cultures maintained in P/S/D, and had been previously shown to promote neuronal differentiation including axonal outgrowth and synapse formation by activating canonical WNT signaling 18, 19 . Notably, P8S10D cells maintained with P/S/D/C for only 8 d (day 16 of differentiation from pluripotent state) yielded neurons with mature electrophysiological properties characterized by the spontaneous firing of trains of action potentials at rest membrane potential or upon induced hyperpolarization after −10 pA current injection (Fig. 4b) . In all conditions, 70-80% of the neurons recorded were capable of firing, with ~20-30% neurons showed more mature firing patterns (~train of ten action potential firing peaks) in P8S10D cells with P/S/D/C (Fig. 4c,d) .
Additional parameters of neuronal maturation include resting membrane potential, action potential half-width and rise rate (Tau) of initial firing, input resistance and maximum firing frequency (Fig. 4e) . While maintaining P8S10D cells in P/S/D/C resulted in the most mature neuronal properties, even the mildest condition (P1S5D cells with basal medium) resulted in neurons with mature firing patterns by day 37 (Supplementary Fig. 7) . This time frame is considerably faster than that achieved by most previous hPSC-based cortical neuron differentiation methods 8, 9 without the use of specialized neuronal recording media 20 , which may accelerate the onset of neuronal activity. We observed robust voltage-dependent sodium channel responses that could be blocked by tetrodotoxin (TTX) (Fig. 4f) . In addition, cells exhibited spontaneous excitatory postsynaptic currents that could be inhibited by NBQX, a specific AMPA receptor antagonist (Fig. 4g) , indicating the formation of functional excitatory synapses. While those functional maturation data were obtained in the absence of any astrocyte co-culture, we tested whether the addition of astrocytes would further accelerate the maturation or promote the maintenance of the neurons. Indeed, culturing P8S10D-derived neurons on mouse astrocytes or in astrocyte-conditioned medium in the presence of DAPT (Supplementary Fig. 8a-c) improved overall neuronal survival and enabled long-term maintenance of rapidly induced neurons from 70 d to beyond 90 d (Supplementary Fig. 8d ). Cultures on astrocytes further yielded neurons with decreased input resistance and enhanced morphological complexity, indicating increased neuronal maturity (Supplementary Fig. 8e-g) .
In vivo studies using iDISCO whole-brain analysis The in vitro data demonstrate that our combinatorial small-molecule protocols can rapidly induce cortical neurons with functional electrophysiological properties. However, to assess long-term survival and the capacity for axonal projections and integration into host circuitry, we performed in vivo transplantation studies. Immature neurons derived from day 8 cultures using an hESC line constitutively expressing EGFP were grafted into the somatosensory cortex of P2 NOD-SCID IL2Rgc -/mice. Brains of the grafted animals were collected at 1-6 months after grafting, and subjected to whole-brain immunofluorescence imaging following the iDISCO 21 clearing and whole-mount immunohistochemistry protocol (Fig. 5a) . Most transplantation studies were carried out using the P1S5D-treated cells, which showed robust in vivo survival up to 6 months after transplantation, the latest time point tested in our study. P8S10D neurons showed more variable in vivo survival, with evidence of engraftment and axonal projections in only a subset of the animals at 1 month A r t i c l e s after transplantation (Supplementary Fig. 9a ). Matched day 8 cells from the LSB+X condition showed extensive graft overgrowth with minimal evidence of neuronal differentiation or graft integration (Supplementary Fig. 9b ). These data are reminiscent of previous results suggesting that early neuroepithelial, 'rosette-stage' cells result in tumor-like overgrowth 22 . Therefore, differentiation of neuroepithelial cells toward later-stage neural precursors or neurons is critical in reducing the risk of neural overgrowth. Analysis of brains grafted with P1S5D neurons at 1 and 1.5 months after grafting allowed visualization of the graft core and neuronal projections ( Fig. 5b and Supplementary Video 1) . After 1 month, GFP + -grafted cells developed extensive defasciculated projections across all cortical layers. A few long dense bundles were also consistently seen in cortical layer VI. Most of the projections terminated in the prefrontal motor cortex and frontal cortex, although many axons were also traced in the ipsilateral hippocampus and contralateral cortex through the corpus callosum ( Fig. 5b and Supplementary Video 1) . Very sparse graft-derived fibers were observed in the striatum, suggesting that grafted neurons preferred projecting across cortical regions rather than targeting subpallial regions. Using autofluorescence to map host axonal pathways (Supplementary Fig. 10a ), we observed that the majority of graft-derived fiber bundles followed endogenous tracts (Supplementary Fig. 10b ). However, some fibers projected outside of the host 'descending tracts' (Supplementary  Fig. 10c) . Overall, P1S5D grafts at 1 and 1.5 months after grafting showed enlarged terminal structures reminiscent of growth cones, a pattern characteristic of ongoing pathfinding with only limited terminal arborization (Fig. 5c, left) . In contrast, by 3 months after transplantation and most pronounced at 6 months (Fig. 5c, middle  and right, and Supplementary Video 2) , there was extensive terminal arborization of human axons in matched target areas (Fig. 5c , middle versus left panel). Concomitant with extensive arborization, we also observed a dense network of human synaptophysin-positive structures colocalized with the GFP + fibers in several target areas, such as the host hippocampus (Fig. 5c, bottom right) . The grafted neurons exhibited a range of morphologies, with unipolar, bipolar, multipolar and pyramidal shapes (Supplementary Fig. 10d) .
iDISCO was complemented with conventional immunohistochemical analyses, which confirmed in vivo cortical marker expression in human cells. These markers included general forebrain marker FOXG1, and layer-specific markers such as REELIN, SATB2 and CTIP2 (Fig. 5d) . Expression of SATB2 + in the grafted neurons was consistent with commissural neuron identity, matching the presence of commissural axonal projections in the iDISCO studies ( Fig. 5c  and Supplementary Video 1) . In addition, we gained preliminary evidence of in vivo function of grafted cells by electrophysiology ( Supplementary Fig. 11 ). Our data indicated that P1S5D-induced neural cells at day 8 of differentiation were capable of in vivo survival and extensive axonal projections within the cortex. While P8S10Dinduced neurons showed overall reduced graft size and viability, animals with surviving grafts showed extensive fiber outgrowth and arborization already at 1.5 months.
DISCUSSION
We present a protocol to generate early-born cortical neurons, in particular of layer VI identity, that have mature electrophysiological properties by day 16 of differentiation and are capable of in vivo engraftment and long-distance projections in the postnatal mouse cortex (Fig. 6) . This time frame is more than twice as fast as that demonstrated in previous cortical neuron differentiation protocols 8, 9, [23] [24] [25] , faster than most extrinsic-factor-based strategies for other hPSC-derived neuronal subtypes [24] [25] [26] and similar in speed to protocols that rely on the forced expression of neurogenic transcription factors such as NGN2 (ref. 26 ). The use of small molecules avoids genetic modification and may offer greater flexibility than transcription factor-based methods. The cortical neurons derived under the current P1S5D or P8S10D conditions are biased toward deep cortical layers. Although our study was focused on manipulating the timing of neuron induction and maturation as independent parameters in hPSC differentiation protocols, we provide preliminary evidence that the culture conditions can be adapted to upper-layer neurons, albeit at a slower time scale.
To our knowledge, there have been no previous reports using iDISCO to map hPSC-derived graft survival, axonal projections or host innervation. The iDISCO data include whole-brain immunohistochemistry and imaging for GFP, as well as imaging of humanspecific markers such as human synaptophysin. This technology should be suitable for use with most human-specific markers to monitor graft biology. In future studies, it may be particularly interesting to apply iDISCO to map region-specific projections of defined hPSCderived cortical lineages, such cells with selective cortical area and layer identity 22 , or to directly compare in vivo survival and projection patterns of distinct hPSC-derived neuronal subtypes injected at identical grafting sites. The assay could also serve as a tool to define neurons of related lineages but distinct projection patterns, such as midbrain dopamine neurons of A9 (substantia nigra) versus A10 (ventral tegmental area) identity, and to map terminal projection patterns of neurons placed at heterotopic 27 versus orthotopic locations 28 .
Further studies are needed to optimize the derivation of layerspecific neurons and to understand the timing for generating deep versus upper layers. We propose that similar small-molecule acceleration strategies may also be developed for additional neuron subtypes. Such rapid, directed differentiation protocols will facilitate the generation of specific neuron subtypes relevant to diverse applications, including disease modeling, drug discovery and cell therapy.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
